Osborne RJ - Search Results

1

Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia.

Osborne RJ, Filiaci VL, Schink JC, Mannel RS, Behbakht K, Hoffman JS, Spirtos NM, Chan JK, Tidy JA, Miller DS. Osborne RJ, et al. Obstet Gynecol. 2016 Sep;128(3):535-542. doi: 10.1097/AOG.0000000000001554. Obstet Gynecol. 2016. PMID: 27500329 Free PMC article. Clinical Trial.

2

High-dose methotrexate for gestational trophoblastic disease.

Elit L, Covens A, Osborne R, Gerulath A, Murphy J, Rosen B, Sturgeon J. Elit L, et al. Gynecol Oncol. 1994 Sep;54(3):282-7. doi: 10.1006/gyno.1994.1211. Gynecol Oncol. 1994. PMID: 7522198 Clinical Trial.

3

What is the best regimen for low-risk gestational trophoblastic neoplasia? A review.

Osborne R, Gerulath A. Osborne R, et al. J Reprod Med. 2004 Aug;49(8):602-16. J Reprod Med. 2004. PMID: 15457850 Review.

4

Successful salvage of relapsed high-risk gestational trophoblastic neoplasia patients using a novel paclitaxel-containing doublet.

Osborne R, Covens A, Mirchandani D, Gerulath A. Osborne R, et al. J Reprod Med. 2004 Aug;49(8):655-61. J Reprod Med. 2004. PMID: 15457856

5

Sonographic diagnosis of gestational trophoblastic disease and comparison with retained products of conception.

Betel C, Atri M, Arenson AM, Khalifa M, Osborne R, Tomlinson G. Betel C, et al. J Ultrasound Med. 2006 Aug;25(8):985-93. doi: 10.7863/jum.2006.25.8.985. J Ultrasound Med. 2006. PMID: 16870892

6

Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group study.

Covens A, Filiaci VL, Burger RA, Osborne R, Chen MD; Gynecologic Oncology Group. Covens A, et al. Cancer. 2006 Sep 15;107(6):1280-6. doi: 10.1002/cncr.22118. Cancer. 2006. PMID: 16900525 Free article. Clinical Trial.

7

First line chemotherapy in low risk gestational trophoblastic neoplasia.

Alazzam M, Tidy J, Hancock BW, Osborne R. Alazzam M, et al. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007102. doi: 10.1002/14651858.CD007102.pub2. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2012 Jul 11;(7):CD007102. doi: 10.1002/14651858.CD007102.pub3 PMID: 19160319 Updated. Review.

8

"Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases".

Seckl MJ, Savage PM, Hancock BW, Berkowitz RS, Goldstein DP, Lurain JR, Schink JC, Cagayan FM, Golfier F, Ngan H, Wake N, Osborne R, Sasaki S, Charry RC, Wong LC, Sekharan PK, Djamhoer MA, Massuger L, Belfort P, Kim SJ, Lee C, Jung SG. Seckl MJ, et al. Gynecol Oncol. 2010 Jun;117(3):505-6; author reply 506-7. doi: 10.1016/j.ygyno.2010.01.016. Epub 2010 Feb 23. Gynecol Oncol. 2010. PMID: 20181383 No abstract available.

9

Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.

Osborne RJ, Filiaci V, Schink JC, Mannel RS, Alvarez Secord A, Kelley JL, Provencher D, Scott Miller D, Covens AL, Lage JM. Osborne RJ, et al. J Clin Oncol. 2011 Mar 1;29(7):825-31. doi: 10.1200/JCO.2010.30.4386. Epub 2011 Jan 24. J Clin Oncol. 2011. PMID: 21263100 Free PMC article. Clinical Trial.

10

Gestational trophoblastic neoplasia.

Osborne R, Dodge J. Osborne R, et al. Obstet Gynecol Clin North Am. 2012 Jun;39(2):195-212. doi: 10.1016/j.ogc.2012.03.002. Obstet Gynecol Clin North Am. 2012. PMID: 22640711 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters